<?xml version="1.0" ?><rss xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" version="2.0"><channel><title>News Detail</title><link>http://localhost/NewsRss.aspx</link><description>This is a short desc</description><item><title>Paths of Progress app expands to Android and Kindle Fire</title><link>http://www.dana-farber.org/Newsroom/News-Releases/Paths-of-Progress-app-expands-to-Android-and-Kindle-Fire.aspx</link><description><em>Paths of Progress</em>, Dana-Farber’s award-winning cancer research magazine, is now available as a free app for iPad, Android and Kindle Fire tablets.</description><author>Aniket</author><pubDate>Tue, 15 May 2012 00:00:00 GMT</pubDate></item><item><title>Dana-Farber Cancer Institute recognizes Oncology Nursing Month</title><link>http://www.dana-farber.org/Newsroom/News-Releases/Dana-Farber-Cancer-Institute-recognizes-Oncology-Nursing-Month.aspx</link><description>During Oncology Nursing Month, Dana-Farber proudly recognizes its dedicated, expert nursing professionals, who serve many functions along the continuum of care. Our nurses also received recognition from national peers and local patients.</description><author>Aniket</author><pubDate>Mon, 14 May 2012 00:00:00 GMT</pubDate></item><item><title>New under the sun: recurrent genetic mutations in melanoma</title><link>http://www.dana-farber.org/Newsroom/News-Releases/new-under-the-sun-recurrent-genetic-mutations-in-melanoma.aspx</link><description>Scientists from Dana-Farber and the Broad Institute have sequenced 25 melanoma tumors and confirmed the long-held suspicion that chronic sun exposure plays a role in skin cancer.</description><author>Aniket</author><pubDate>Wed, 09 May 2012 00:00:00 GMT</pubDate></item><item><title>American Society for Clinical Investigation honors Kaelin</title><link>http://www.dana-farber.org/Newsroom/News-Releases/american-society-for-clinical-investigation-honors-kaelin.aspx</link><description>William G. Kaelin, Jr., MD, received the 2012 American Society for Clinical Investigation’s Stanley J. Korsmeyer Award in recognition of his contributions to the molecular understanding of cellular oxygen sensing and cellular adaptation to hypoxia.</description><author>Aniket</author><pubDate>Wed, 02 May 2012 00:00:00 GMT</pubDate></item><item><title>Advanced pancreatic tumors depend on continued oncogene activity</title><link>http://www.dana-farber.org/Newsroom/News-Releases/advanced-pancreatic-tumors-depend-on-continued-oncogene-activity.aspx</link><description>Dana-Farber researchers report that advanced pancreatic cancers are dependent on the continued expression of a mutant oncogene that "rewires" key metabolic pathways, which suggests that these altered pathways might be potential targets for future drugs.</description><author>Aniket</author><pubDate>Mon, 30 Apr 2012 00:00:00 GMT</pubDate></item><item><title>Adding drug to standard chemotherapy provides no survival benefit for older lung cancer patients</title><link>http://www.dana-farber.org/Newsroom/News-Releases/adding-drug-to-standard-chemotherapy-provides-no-survival-benefit-for-older-lung-cancer-patients.aspx</link><description>Adding Avastin to standard chemotherapy treatment may not improve survival rates for people with non-small cell lung cancer aged 65 plus, according to Dana-Farber researchers, who further suggest that clinicians exercise caution in including the drug in treatment recommendations.</description><author>Aniket</author><pubDate>Tue, 17 Apr 2012 00:00:00 GMT</pubDate></item><item><title>Social ties have mixed impact on encouraging healthy behaviors in low-income areas</title><link>http://www.dana-farber.org/Newsroom/News-Releases/social-ties-have-mixed-impact-on-encouraging-healthy-behaviors-in-low-income-areas.aspx</link><description>Strong social connections may make it harder for some people who live in low-income, minority communities to lead a healthy lifestyle, <br />report Dana-Farber and Harvard School of Public Health researchers.</description><author>Aniket</author><pubDate>Fri, 13 Apr 2012 00:00:00 GMT</pubDate></item><item><title>Dana-Farber unveils contemporary art collection, audio tour in Yawkey Center for Cancer Care</title><link>http://www.dana-farber.org/Newsroom/News-Releases/dana-farber-unveils-contemporary-art-collection-audio-tour.aspx</link><description>Dana-Farber is further enhancing the patient experience with a contemporary art collection of nearly 500 works by both local and internationally renowned artists throughout the Yawkey Center. A new audio guide allows cancer patients and families to learn more about the artwork.</description><author>Aniket</author><pubDate>Wed, 11 Apr 2012 00:00:00 GMT</pubDate></item><item><title>American Association for Cancer Research honors D&#39;Andrea</title><link>http://www.dana-farber.org/newsroom/news-releases/american-association-for-cancer-research-honors-dandrea.aspx</link><description>The American Association for Cancer Research named Alan D. D'Andrea, MD, the recipient of the 52nd Annual AACR G.H.A. Clowes Memorial Award for his work in understanding cancer survival and progression.</description><author>Aniket</author><pubDate>Fri, 06 Apr 2012 00:00:00 GMT</pubDate></item><item><title>First targeted nanomedicine to enter cancer clinical studies</title><link>http://www.dana-farber.org/newsroom/news-releases/first-targeted-nanomedicine-to-enter-cancer-clinical-studies.aspx</link><description>A multi-institutional team of researchers has published a study that demonstrates a novel therapy works against solid tumors. It is the first targeted and programmed nanomedicine to enter human clinical studies.</description><author>Aniket</author><pubDate>Fri, 06 Apr 2012 00:00:00 GMT</pubDate></item><item><title>Stand Up To Cancer and Prostate Cancer Foundation Announce New Dream Team</title><link>http://www.dana-farber.org/Newsroom/News-Release/stand-up-to-cancer-and-prostate-cancer-foundation-announce-new-dream-team.aspx</link><description>A new SU2C and Prostate Cancer Foundation Dream Team, dedicated to advanced prostate cancer research, includes two Dana-Farber researchers among scientists from leading prostate cancer centers in the U.S. and England.</description><author>Aniket</author><pubDate>Mon, 02 Apr 2012 00:00:00 GMT</pubDate></item><item><title>Writing the book of cancer knowledge</title><link>http://www.dana-farber.org/newsroom/news-releases/writing-the-book-of-cancer-knowledge.aspx</link><description>Dana-Farber scientists and colleagues have published results from the Cancer Cell Line Encyclopedia, a resource that marries cancer genome data with predictors of drug responses. This information could refine cancer clinical trials and future treatments.</description><author>Aniket</author><pubDate>Fri, 30 Mar 2012 00:00:00 GMT</pubDate></item><item><title>U.S. cancer death rates continue to decline, national report finds</title><link>http://www.dana-farber.org/Newsroom/News-Releases/us-cancer-death-rates-continue-to-decline-national-report-finds.aspx</link><description>Dana-Farber president Edward J. Benz, MD, comments on a report showing decline in rates of death in the U.S. from all cancers for men and women. The findings come from the latest Annual Report to the Nation on the Status of Cancer.</description><author>Aniket</author><pubDate>Wed, 28 Mar 2012 00:00:00 GMT</pubDate></item><item><title>&#39;Co-clinical trials&#39; help focus lung cancer research</title><link>http://www.dana-farber.org/Newsroom/News-Releases/co-clinical-trials-help-focus-lung-cancer-research.aspx</link><description>By conducting simultaneous clinical trials in patients and labs, Dana-Farber researchers and colleagues have been able to predict how patients with non-small cell lung cancer respond to combination therapy.</description><author>Aniket</author><pubDate>Wed, 28 Mar 2012 00:00:00 GMT</pubDate></item><item><title>DNA marker predicts platinum drug response in breast, ovarian cancer</title><link>http://www.dana-farber.org/Newsroom/News-Releases/DNA-marker-predicts-platinum-drug-response-in-breast-ovarian-cancer.aspx</link><description>Scientists from Brigham and Women's Hospital and Dana-Farber Cancer Institute and their colleagues have found a genetic marker that predicts which aggressive "triple negative" breast cancers and certain ovarian cancers will likely respond to platinum-based chemotherapies.</description><author>Aniket</author><pubDate>Fri, 23 Mar 2012 00:00:00 GMT</pubDate></item><item><title>Colon cancer on the rise in young adults</title><link>http://www.dana-farber.org/Newsroom/News-Releases/Colon-cancer-on-the-rise-in-young-adults.aspx</link><description>Colorectal cancer is the second leading cause of cancer deaths in the United States. Many people have no symptoms in the early stages of the disease. Doctors are reminding people about the importance of being regularly screened to help save lives.</description><author>Aniket</author><pubDate>Wed, 07 Mar 2012 00:00:00 GMT</pubDate></item><item><title>Dana-Farber’s Belfer Institute for Applied Cancer Science appoints new head of research</title><link>http://www.dana-farber.org/newsroom/news-releases/belfer-institute-for-applied-cancer-science-appoints-head-of-research.aspx</link><description>Jessie M. English, PhD, has been appointed the head of Research of the Belfer Institute for Applied Cancer Science at Dana-Farber. The Belfer Institute offers the full array of innovative drug discovery capabilities, from the identification of cancer-causing genetic mutations to the validation and selection of new drug targets.</description><author>Aniket</author><pubDate>Thu, 01 Mar 2012 00:00:00 GMT</pubDate></item><item><title>Researchers identify new subtype of ovarian cancer may be vulnerable to anti-angiogenic drugs</title><link>http://www.dana-farber.org/Newsroom/News-Releases/new-subtype-of-ovarian-cancer-may-be-vulnerable-to-anti-angiogenic-drugs.aspx</link><description>The discovery of a subtype of ovarian cancer that could account for up to one-third of all serous ovarian cancers may lead to clinical trials using anti-angiogenic drugs that are already being tested in other cancers.</description><author>Aniket</author><pubDate>Wed, 15 Feb 2012 00:00:00 GMT</pubDate></item><item><title>Justin Bieber Dream Date Shines Light on Rare Pediatric Cancer</title><link>http://www.dana-farber.org/Newsroom/News-Releases/justin-bieber-dream-date-shines-light-on-rare-pediatric-cancer.aspx</link><description>Justin Bieber's date with young brain tumor patient Avalanna Routh has focused attention on atypical teratoid rhabdoid tumor, or AT/RT. Mark Kieran, MD, PhD, of Dana-Farber/Children's Hospital Cancer Center, discusses this rare cancer.<br /></description><author>Aniket</author><pubDate>Tue, 14 Feb 2012 00:00:00 GMT</pubDate></item><item><title>Newly identified fusion genes in lung and colorectal cancer may guide treatment with &#39;targeted&#39; drugs</title><link>http://www.dana-farber.org/Newsroom/News-Releases/newly-identified-fusion-genes-in-lung-and-colorectal-cancer-may-guide-treatment-with-targeted-drugs.aspx</link><description>Newly discovered gene mutations in certain non-small cell and colorectal cancers share similarities with other genetic abnormalities that are known to respond to targeted cancer treatments. This suggests that existing therapies, already approved, could be used to treat patients with these tumors.</description><author>Aniket</author><pubDate>Mon, 13 Feb 2012 00:00:00 GMT</pubDate></item><item><title>Cupid takes on cancer</title><link>http://www.dana-farber.org/Newsroom/News-Releases/cupid-takes-on-cancer.aspx</link><description>With Valentine's Day around the corner, show that special someone how much you care. Dana-Farber nutritionist Stephanie Meyers shares ways to say "I love you" with delicious desserts packed with the cancer-fighting phytonutrients in raspberries, pomegranates, berries, and mango.</description><author>Aniket</author><pubDate>Fri, 10 Feb 2012 00:00:00 GMT</pubDate></item><item><title>Most terminally ill cancer patients discuss end-of-life care with physician, study finds, but often late in their illness</title><link>http://www.dana-farber.org/Newsroom/News-Releases/most-terminally-ill-cancer-patients-discuss-end-of-life-care-with-physician-study-finds.aspx</link><description>A study led by Jennifer Mack, MD, MPH, suggests that many terminally ill cancer patients do talk with a doctor about their preferences for end-of-life care, but those conversations often occur late in the course of their illness and tend to be with a hospital-based physician and not their oncologist who has been caring for them.</description><author>Aniket</author><pubDate>Wed, 08 Feb 2012 00:00:00 GMT</pubDate></item><item><title>Dana-Farber/Children&#39;s Hospital Cancer Center experts recommend genetic counseling for pediatric sarcoma patients</title><link>http://www.dana-farber.org/Newsroom/News-Releases/Dana-Farber-Childrens-Hospital-Cancer-Center-experts-recommend-genetic-counseling-for-pediatric-sarcoma-patients.aspx</link><description>Genetic specialists at Dana-Farber/Children’s Hospital Cancer Center (DF/CHCC) are recommending that children being treated for sarcoma should be offered genetic counseling for Li-Fraumeni syndrome, a rare condition that greatly raises a person’s risk of developing additional cancers</description><author>Aniket</author><pubDate>Wed, 08 Feb 2012 00:00:00 GMT</pubDate></item><item><title>Dana-Farber appoints Partridge as director of adult survivorship program</title><link>http://www.dana-farber.org/Newsroom/News-Releases/Dana-Farber-appoints-Partridge-as-director-of-adult-survivorship-program.aspx</link><description>Ann Partridge, MD, MPH, is named the director of Dana-Farber's Adult Survivorship Program and the Lance Armstrong Foundation Clinic. An accomplished clinician-researcher, Partridge is nationally recognized for contributions to the fields of breast cancer in young women and cancer survivorship.</description><author>Aniket</author><pubDate>Tue, 07 Feb 2012 00:00:00 GMT</pubDate></item><item><title>Three &#39;targeted&#39; cancer drugs raise risk of fatal side effects</title><link>http://www.dana-farber.org/Newsroom/News-Releases/three-targeted-cancer-drugs-raise-risk-of-fatal-side-effects.aspx</link><description>Treatment with three "targeted" cancer drugs has been linked to a slightly elevated chance of fatal side effects, according to a new analysis led by scientists at Dana-Farber. These risks remain low, but they should be factored in when developing patients’ treatment plans.</description><author>Aniket</author><pubDate>Mon, 06 Feb 2012 00:00:00 GMT</pubDate></item><item><title>World Cancer Day points to prevention</title><link>http://www.dana-farber.org/Newsroom/News-Releases/World-Cancer-Day-points-to-prevention.aspx</link><description>World Cancer Day is Saturday, February 4th. Focusing on this year's theme of prevention, Dana-Farber's Judy Garber, MD, MPH, says simple lifestyle changes can reduce your cancer risk.</description><author>Aniket</author><pubDate>Fri, 03 Feb 2012 00:00:00 GMT</pubDate></item><item><title>Sunscreen still &#39;applies&#39; in winter months</title><link>http://www.dana-farber.org/Newsroom/News-Releases/sunscreen-still-applies-in-winter-months.aspx</link><description>It's still possible to get too much sun exposure in winter. Dana-Farber's skin cancer specialists explain the dangers and offer sun safety tips to help you protect your skin while enjoying outdoor winter activities.</description><author>Aniket</author><pubDate>Wed, 01 Feb 2012 00:00:00 GMT</pubDate></item><item><title>Massachusetts Life Sciences Center grant expands Dana-Farber&#39;s cancer imaging research program</title><link>http://www.dana-farber.org/Newsroom/News-Releases/Massachusetts-Life-Sciences-Center-grant-expands-Dana-Farber-s-cancer-imaging-research-program.aspx</link><description>The Massachusetts Life Sciences Center has awarded Dana-Farber Cancer Institute a $10 million grant to support the expansion of its pioneering cancer imaging research program with a new imaging facility which will support more rapid assessment of therapies and play a key role in the delivery of personalized medicine.</description><author>Aniket</author><pubDate>Tue, 31 Jan 2012 00:00:00 GMT</pubDate></item><item><title>&#39;Pulverized&#39; chromosomes linked to cancer?</title><link>http://www.dana-farber.org/Newsroom/News-Releases/-Pulverized--chromosomes-linked-to-cancer-.aspx</link><description>In a paper published online yesterday by the journal Nature, Dana-Farber researchers map out a mechanism by which micronuclei could potentially disrupt the chromosomes within them and produce cancer-causing gene mutations. The findings may point to a vulnerability in cancer cells that could be attacked by new therapies.</description><author>Aniket</author><pubDate>Thu, 19 Jan 2012 00:00:00 GMT</pubDate></item><item><title>New iPad app brings Paths of Progress to life</title><link>http://www.dana-farber.org/Newsroom/News-Releases/New-iPad-app-brings-Paths-of-Progress-to-life.aspx</link><description>Dana-Farber is expanding its digital publishing efforts with the launch of <em>Paths of Progress</em>, the Institute's twice-yearly research and care magazine, as an iPad  application enhanced with animations and web links.</description><author>Aniket</author><pubDate>Wed, 18 Jan 2012 00:00:00 GMT</pubDate></item><item><title>Researchers isolate messenger protein linking exercise to health benefits</title><link>http://www.dana-farber.org/Newsroom/News-Releases/Researchers-isolate-messenger-protein-linking-exercise-to-health-benefits.aspx</link><description>Researchers have isolated a natural hormone from muscle cells that triggers some of the key health benefits of exercise. Irisin, which switches on genes that convert white fat into "good" brown fat, may hold promise as a novel treatment for diabetes, obesity and perhaps other disorders, including cancer.</description><author>Aniket</author><pubDate>Wed, 11 Jan 2012 00:00:00 GMT</pubDate></item><item><title>Ring in a new healthier you in 2012</title><link>http://www.dana-farber.org/Newsroom/News-Releases/Ring-in-a-new-healthier-you-in-2012.aspx</link><description>Are you making New Year's resolutions? Dana-Farber Cancer Institute experts are encouraging people to ring in new healthy habits in 2012. Here are a number of free and low-cost strategies to help people maintain good health and possibly reduce various cancer risks.</description><author>Aniket</author><pubDate>Wed, 28 Dec 2011 00:00:00 GMT</pubDate></item><item><title>Targeting EETs to treat cardiovascular disease may prove a double-edged sword</title><link>http://www.dana-farber.org/Newsroom/News-Releases/Targeting-EETs-to-treat-cardiovascular-disease-may-prove-a-double-edged-sword.aspx</link><description>A study documents the connection between increased levels of epoxyeicosatrienoic acids (EET) lipids and cancer growth and metastasis opening the door to a new avenue for cancer treatment.</description><author>Aniket</author><pubDate>Mon, 19 Dec 2011 00:00:00 GMT</pubDate></item><item><title>Dana-Farber offers healthy holiday recipes and food tips</title><link>http://www.dana-farber.org/Newsroom/News-Releases/Dana-Farber-offers-healthy-holiday-recipes-and-food-tips.aspx</link><description>The holidays are a great time to bring cancer-fighting foods to the table. Nutritionist Stephanie Meyers, MS, RD/LDN, discusses some holiday favorites that also contain cancer-preventing nutrients and shares recipes that highlight these beneficial ingredients.</description><author>Aniket</author><pubDate>Thu, 15 Dec 2011 00:00:00 GMT</pubDate></item><item><title>Therapy improves stem cell engraftment in umbilical cord blood transplant recipients</title><link>http://www.dana-farber.org/Newsroom/News-Releases/Therapy-improves-stem-cell-engraftment-in-umbilical-cord-blood-transplant-recipients.aspx</link><description>A therapy involving a natural compound may improve the ability of stem cells from umbilical cord blood to engraft in patients receiving a stem cell transplant for cancer or other diseases.</description><author>Aniket</author><pubDate>Mon, 12 Dec 2011 00:00:00 GMT</pubDate></item><item><title>Peptide &#39;cocktail&#39; elicits immune response to multiple myeloma</title><link>http://www.dana-farber.org/Newsroom/News-Releases/peptide-cocktail-elicits-immune-response-to-multiple-myeloma.aspx</link><description>Scientists have created a "cocktail" combination of four antigenic peptides derived from myeloma cells they believe could provoke the body's defenses to attack multiple myeloma in its early "smoldering" phase and slow or prevent the blood cancer.</description><author>Aniket</author><pubDate>Mon, 12 Dec 2011 00:00:00 GMT</pubDate></item><item><title>Researchers identify genetic mutation responsible for most cases of Waldenström&#39;s macroglobulinemia</title><link>http://www.dana-farber.org/Newsroom/News-Releases/researchers-identify-genetic-mutation-responsible-for-most-cases-of-waldenstroms-macroglobulinemia.aspx</link><description>Scientists at Dana-Farber Cancer Institute have identified a gene mutation that underlies the vast majority of cases of Waldenström's macroglobulinemia, a rare form of lymphoma that has eluded all previous efforts to find a genetic cause.</description><author>Aniket</author><pubDate>Mon, 12 Dec 2011 00:00:00 GMT</pubDate></item><item><title>Former Dana-Farber president receives lifetime achievement award</title><link>http://www.dana-farber.org/Newsroom/News-Releases/Former-Dana-Farber-president-receives-lifetime-achievement-award.aspx</link><description>David G. Nathan, MD, president emeritus of Dana-Farber, was bestowed with the highest honor give by the American Society of Hematology: the Wallace H. Coulter Award for Lifetime Achievement in Hematology.</description><author>Aniket</author><pubDate>Mon, 12 Dec 2011 00:00:00 GMT</pubDate></item><item><title>Massive DNA search uncovers new mutations driving blood cancer</title><link>http://www.dana-farber.org/Newsroom/News-Releases/Massive-DNA-search-uncovers-new-mutations-driving-blood-cancer.aspx</link><description>Researchers have found several new altered genes that drive chronic lymphocitic leukemia through powerful DNA sequencing, a finding that could potentially help doctors predict whether a patient’s disease will progress rapidly or remain indolent for years.</description><author>Aniket</author><pubDate>Mon, 12 Dec 2011 00:00:00 GMT</pubDate></item><item><title>Experimental drug combination &#39;encouraging&#39; in relapsed multiple myeloma</title><link>http://www.dana-farber.org/Newsroom/News-Releases/Experimental-drug-combination--encouraging--in-relapsed-multiple-myeloma.aspx</link><description>A phase 2 clinical trial has shown that pairing bortezomib with an experimental drug, panobinostat, may be a promising treatment for patients with advanced multiple myeloma when the targeted drug bortezomib stops working alone.</description><author>Aniket</author><pubDate>Mon, 12 Dec 2011 00:00:00 GMT</pubDate></item><item><title>&#39;Twinning&#39; U.S.-based and Rwandan physicians improves lymphoma outcomes in children</title><link>http://www.dana-farber.org/Newsroom/News-Releases/twinning-us-based-and-rwandan-physicians-improves-lymphoma-outcomes-in-children.aspx</link><description>"Twinning" U.S.-based and Rwandan physicians in a team approach has shown to improve lymphoma outcomes in children in a country lacking any specialists in children's cancers.</description><author>Aniket</author><pubDate>Mon, 12 Dec 2011 00:00:00 GMT</pubDate></item><item><title>Researchers identify a novel therapeutic approach for liver cancer</title><link>http://www.dana-farber.org/Newsroom/News-Releases/Researchers-identify-a-novel-therapeutic-approach-for-liver-cancer.aspx</link><description>Researchers have identified a mechanism that triggers inflammation in the liver and transforms normal cells into cancerous ones, a finding that could lead to the treatment or prevention of liver cancer.</description><author>Aniket</author><pubDate>Fri, 09 Dec 2011 00:00:00 GMT</pubDate></item><item><title>Dana-Farber launches cancer blog</title><link>http://www.dana-farber.org/Newsroom/News-Releases/Dana-Farber-launches-cancer-blog.aspx</link><description>Dana-Farber has launched Insight, a new blog providing expert commentary on cancer research news, patient care, and issues relevant to people with cancer and their families.</description><author>Aniket</author><pubDate>Fri, 09 Dec 2011 00:00:00 GMT</pubDate></item><item><title>Boston magazine recognizes Dana-Farber physicians as &#39;Top Doctors&#39;</title><link>http://www.dana-farber.org/Newsroom/News-Releases/Boston-magazine-recognizes-Dana-Farber-physicians-as--Top-Doctors-.aspx</link><description><em>Boston</em> magazine has named 56 physicians and surgeons affiliated with Dana-Farber Cancer Institute to its Top Doctors guide. Published in the magazine’s December issue, the Top Doctors list consists of 650 Boston-area physicians from 57 medical specialties.</description><author>Aniket</author><pubDate>Wed, 07 Dec 2011 00:00:00 GMT</pubDate></item><item><title>New study reassures on heart risks of prostate cancer treatment</title><link>http://www.dana-farber.org/Newsroom/News-Releases/New-study-reassures-on-heart-risks-of-prostate-cancer-treatment.aspx</link><description>Hormone-blocking therapy for prostate cancer doesn’t raise the risk of fatal heart attacks - as some recent studies had suggested - according to a new report from Dana-Farber/Brigham and Women’s Cancer Center.</description><author>Aniket</author><pubDate>Tue, 06 Dec 2011 00:00:00 GMT</pubDate></item><item><title>New England Patriots Charitable Foundation kicks off blood and platelet drive  at Dana-Farber and Brigham and Women&#39;s Hospital</title><link>http://www.dana-farber.org/Newsroom/News-Releases/New-England-Patriots-Charitable-Foundation-kicks-off-blood-and-platelet-drive--at-Dana-Farber-and-Brigham-and-Women-s-Hospital.aspx</link><description>The New England Patriots Charitable Foundation continues their efforts to increase awareness of the importance of blood and platelet donations with a drive December 1 through December 31, at the Dana-Farber Cancer Institute Kraft Family Blood Donor Center and the Brigham and Women's Hospital Blood Donor Center, both in the Longwood Medical Area.</description><author>Aniket</author><pubDate>Thu, 01 Dec 2011 00:00:00 GMT</pubDate></item><item><title>New approach to graft-versus-host disease treatment results in sustained improvement for some patients</title><link>http://www.dana-farber.org/Newsroom/News-Releases/New-approach-to-graft-versus-host-disease-treatment-results-in-sustained-improvement-for-some-patients.aspx</link><description>In a study that seems to pivot on a paradox, scientists at Dana-Farber Cancer Institute have used an immune system stimulant as an immune system suppressor to treat a common, often debilitating side effect of donor stem cell transplantation in cancer patients.</description><author>Aniket</author><pubDate>Wed, 30 Nov 2011 00:00:00 GMT</pubDate></item><item><title>Study identifies possible therapy for radiation sickness</title><link>http://www.dana-farber.org/Newsroom/News-Releases/Study-identifies-possible-therapy-for-radiation-sickness.aspx</link><description>A combination of two drugs may alleviate radiation sickness in people who have been exposed to high levels of radiation, even when the therapy is given a day after the exposure occurred, according to a study led by scientists from Dana-Farber Cancer Institute and Children's Hospital Boston</description><author>Aniket</author><pubDate>Wed, 23 Nov 2011 00:00:00 GMT</pubDate></item><item><title>Sam Donaldson speaks at Dana-Farber Visiting Committee Symposium dinner</title><link>http://www.dana-farber.org/Newsroom/News-Releases/Sam-Donaldson-speaks-at-Dana-Farber-Visiting-Committee-Symposium-dinner.aspx</link><description>ABC News' Sam Donaldson shared his experience as a melanoma patient during his keynote speech at the Dana-Farber Cancer Institute Joint Visiting Committee Symposium dinner Nov. 15.</description><author>Aniket</author><pubDate>Mon, 21 Nov 2011 00:00:00 GMT</pubDate></item><item><title>Flash mob music performance strikes the right chord at Dana-Farber</title><link>http://www.dana-farber.org/Newsroom/News-Releases/Flash-mob-music-performance-strikes-the-right-chord-at-Dana-Farber.aspx</link><description>Patients and staff at Dana-Farber Cancer Institute were treated to a surprise performance by Boston's Longwood Symphony Orchestra. Ten musicians took time out their busy days to offer a little "music therapy" with the "flash mob" performance of Bach's Brandenburg Concerto No. 3.</description><author>Aniket</author><pubDate>Fri, 18 Nov 2011 00:00:00 GMT</pubDate></item><item><title>Pan-Massachusetts Challenge Gives $35 million to Jimmy Fund</title><link>http://www.dana-farber.org/Newsroom/News-Releases/Pan-Massachusetts-Challenge-Gives-$35-million-to-Jimmy-Fund.aspx</link><description>On Friday, Nov. 11, the Pan-Massachusetts Challenge (PMC) presents a check for $35 million to Dana-Farber Cancer Institute through its Jimmy Fund. This year's event involved 5,169 cyclists from eight countries and 37 states.</description><author>Aniket</author><pubDate>Fri, 11 Nov 2011 00:00:00 GMT</pubDate></item><item><title>Yawkey Center for Cancer Care&#39;s green design earns gold</title><link>http://www.dana-farber.org/Newsroom/News-Releases/Yawkey-Center-for-Cancer-Care-s-green-design-earns-gold.aspx</link><description>The U.S. Green Building Council awarded Dana-Farber's Yawkey Center for Cancer Care its Leadership in Energy and Environmental Design (LEED®) Gold certification in recognition of its sustainable and green design and construction features.</description><author>Aniket</author><pubDate>Mon, 31 Oct 2011 00:00:00 GMT</pubDate></item><item><title>Research makes it possible to predict how cancers will respond to chemo</title><link>http://www.dana-farber.org/Newsroom/News-Releases/Research-makes-it-possible-to-predict-how-cancers-will-respond-to-chemo.aspx</link><description>Dana-Farber scientists have devised a test that can predict how effective chemotherapy will be by determining whether tumor cells are "primed" for death. The discovery suggests it may be possible to predict which patients will likely benefit from chemo, as well as to make some chemo more effective.</description><author>Aniket</author><pubDate>Thu, 27 Oct 2011 00:00:00 GMT</pubDate></item><item><title>CDC guidelines for vaccinating boys against HPV applauded</title><link>http://www.dana-farber.org/Newsroom/News-Releases/CDC-guidelines-for-vaccinating-boys-against-HPV-applauded.aspx</link><description>Head and neck cancer expert Robert Haddad, MD, comments on the CDC's recommendation that boys should be vaccinated against the human papillomavirus (HPV).</description><author>Aniket</author><pubDate>Tue, 25 Oct 2011 00:00:00 GMT</pubDate></item><item><title>Dana-Farber, Brigham and Women&#39;s launch Profile, a large-scale research program to scan tumors for mutations, establish extensive genomic database</title><link>http://www.dana-farber.org/Newsroom/News-Releases/Dana-Farber,-Brigham-and-Women-s-launch-Profile,-a-large-scale-research-program-to-scan-tumors-for-mutations,-establish-extensive-genomic-database.aspx</link><description>Dana-Farber and Brigham and Women's Hospital have launched Profile, one of the most comprehensive cancer research studies to help accelerate the development of personalized treatments for every person with cancer.</description><author>Aniket</author><pubDate>Mon, 24 Oct 2011 00:00:00 GMT</pubDate></item><item><title>Researchers find possible link between bacterium and colon cancer</title><link>http://www.dana-farber.org/Newsroom/News-Releases/Researchers-find-possible-link-between-bacterium-and-colon-cancer.aspx</link><description>Dana-Farber and the Broad Institute researchers have found high levels of the bacterium Fusobacterium in colorectal cancers, a sign that it might contribute to the disease and potentially lead to further research.</description><author>Aniket</author><pubDate>Mon, 17 Oct 2011 00:00:00 GMT</pubDate></item><item><title>Dialing up fetal hemoglobin dials down sickle cell disease</title><link>http://www.dana-farber.org/Newsroom/News-Releases/Dialing-up-fetal-hemoglobin-dials-down-sickle-cell-disease.aspx</link><description>Dana-Farber Cancer Institute and Children's Hospital Boston researchers have identified a protein that could be a powerful treatment target for sickle cell anemia, a significant global health problem, one that affects between 75,000 and 100,000 people in the United States alone.</description><author>Aniket</author><pubDate>Thu, 13 Oct 2011 00:00:00 GMT</pubDate></item><item><title>Childhood leukemia survivors face lifelong health challenges</title><link>http://www.dana-farber.org/Newsroom/News-Releases/Childhood-leukemia-survivors-face-lifelong-health-challenges.aspx</link><description>Tens of thousands of childhood cancer survivors are now in their 20s, 30s, and beyond, facing life-long risks of treatment-related health issues. Increasingly, primary care physicians will need to be knowledgeable about symptoms and complaints that might be related to cancer treatments their patients received decades ago.</description><author>Aniket</author><pubDate>Wed, 12 Oct 2011 00:00:00 GMT</pubDate></item><item><title>New prostate cancer screening guidelines called into question</title><link>http://www.dana-farber.org/Newsroom/News-Releases/New-prostate-cancer-screening-guidelines-called-into-question.aspx</link><description>Dr. Philip Kantoff says the United States Preventive Services Task Force's conclusion that prostate-specific antigen (PSA) testing provides limited value is the wrong message.</description><author>Aniket</author><pubDate>Fri, 07 Oct 2011 00:00:00 GMT</pubDate></item><item><title>Study finds key to drug resistance</title><link>http://www.dana-farber.org/Newsroom/News-Releases/Study-finds-key-to-drug-resistance.aspx</link><description>A new discovery by Jean Zhao, PhD, and colleagues may help physicians predict which tumors are likely to become resistant to a given drug. In the report, published by <em>Nature Medicine</em>, researchers described how they created a genetically engineered mouse model of human breast cancer in which the most frequently occurring breast cancer oncogene, PIK3CA, could be turned on and off.</description><author>Aniket</author><pubDate>Fri, 23 Sep 2011 00:00:00 GMT</pubDate></item><item><title>Cancer protein&#39;s surprising role as memory regulator</title><link>http://www.dana-farber.org/Newsroom/News-Releases/Cancer-protein-s-surprising-role-as-memory-regulator.aspx</link><description>A Dana-Farber and Harvard Medical School study has found that a protein with well-documented ties to cancer also plays a crucial role in memory formation in the brain, and it may be linked to Alzheimer's disease.</description><author>Aniket</author><pubDate>Thu, 22 Sep 2011 00:00:00 GMT</pubDate></item><item><title>Charlie&#39;s Story–Thriving after Leukemia and Relapse</title><link>http://www.dana-farber.org/Newsroom/News-Releases/Charlie-s-Story–Thriving-after-Leukemia-and-Relapse.aspx</link><description>When Charlie was diagnosed with acute lymphoblastic leukemia at age 4, his mother sent regular email updates to her large family and circle of friends. Her reflections grew into a touching chronicle of four years in the life of a child with cancer.</description><author>Aniket</author><pubDate>Thu, 15 Sep 2011 00:00:00 GMT</pubDate></item></channel></rss>
